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Tendon is a highly organised, dynamic tissue which func-
tions to transmit tensile forces from muscle to bone. Type
I collagen is the major component of the tendon extracellu-
lar matrix (ECM) and it is the ordered arrangement of colla-
gen ﬁbres which is critical in providing the high tensile
strength of this tissue. Within the tendon, the endotenon
(a thin reticular network of connective tissue) surrounds
and binds the ﬁbre bundles or ‘‘fascicles’’, thus facilitating
their physiological functioning1.
Importantly, the assembly (i.e., ﬁbrillogenesis) of type I
collagen in tendon is tightly regulated by small leucine-
rich proteoglycans (SLRPs), and this process underpins
the structural organisation of the tissue2. This is highlighted
by genetic studies utilising mice deﬁcient in one or two of
the prominent SLRPs (i.e., decorin, biglycan, ﬁbromodulin
and lumican) which show clear structural alterations in their
collagen ﬁbrils, frequently resulting in impaired tendon func-
tion3. Within tendon, decorin is the most prevalent SLRP in
regions which experience predominantly longitudinal/ten-
sional forces, however, biglycan, ﬁbromodulin and lumican
have also been detected. In tendon ﬁbrocartilage, which de-
velops in regions compressed against bony pulleys and at
tendon entheses, type II in addition to type I collagen is
present, as well as increased levels of biglycan and other
proteoglycans common to the articular cartilage pheno-
type4,5. Thus, regional differences in the expression of the
various SLRPs in tendon may reﬂect such changes in the
collagenous ECM. Similar to tendon, the ECM of cornea
is composed of a highly ordered, ﬁbrillar collagen network,
and this is essential for the development and maintenance
of corneal strength and transparency6. The keratan sul-
phate (KS)-containing SLRPs, lumican and keratocan,
play a pivotal role in collagen ﬁbrillogenesis in this tissue;aThese authors have contributed equally to this work.
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276signiﬁcantly, the absence of lumican leads to formation of
cloudy corneas in homozygous knockout mice3, whilst
those deﬁcient in keratocan develop signiﬁcantly larger di-
ameter corneal collagen ﬁbrils7.
Although a number of SLRPs have been identiﬁed and bi-
ochemically characterised in tendon, few studies have ex-
amined keratocan distribution and expression in this
tissue. The present study was therefore conducted using
bovine tendons from compressed/ﬁbrocartilaginous and
tensional regions to determine the immunolocalisation of
keratocan in these distinct functional regions, using a new
monoclonal antibody (mAb), KER-1, which recognises
a protein epitope on the keratocan core protein. In addition,
Western blot analysis was used to compare the expression
of this SLRP in tissue extracts of tendon (ﬁbrocartilaginous
vs tensional), articular cartilage and cornea. The results of
this study suggest that keratocan, previously thought to
be ‘corneal-speciﬁc’8,9, is also abundant in tendon and is
likely to play an important role in regulating the collagenous
matrix of this tissue.Methods, results and discussion
Bovine deep digital ﬂexor tendons from compressed and
tensional regions were dissected from the metacarpopha-
langeal joints of mature (18-month-old) animals10. Ten-
sional samples were comprised of tissue located proximal
to bifurcation of the tendon and compressed samples
were composed of ﬁbrocartilaginous tissue from the region
of tendon distal to the bifurcation11. Full-depth articular car-
tilage was also dissected from the corresponding metacar-
pophalangeal joints. Corneas were harvested from the
ocular globes of 18-month-old cattle.
For immunohistochemical analyses, tendon sections
(cryosectioned at 10 mm in a transverse plane) were treated
with chondroitinase ABC (0.4 U/ml), keratanase (0.4 U/ml),
keratanase II (0.2 U/ml) and endo-b-galactosidase
(0.002 U/ml) for 1 h at 37C. Sections were subsequently
blocked using 5% goat serum in 0.1% Tween/phosphate
buffered saline (PBS) for 30 min and immunolabelled by in-
direct immunoﬂuorescence using mAb KER-1 (1:10 dilution
in 0.1% Tween/PBS and applied overnight at 4C), which
Fig. 1. Immunolocalisation of keratocan in mature bovine deep digital ﬂexor tendon. (A) Transverse section of compressed tendon immunola-
belled with mAb KER-1 (shown in red) which recognises the keratocan core protein and polyclonal antibody 70-XR90 (shown in green) which
recognises type I collagen. Areas of co-localisation of keratocan/collagen I immunolabelling are shown in yellow. Cell nuclei are shown in blue.
Positive immunolabelling of tendon collagen ﬁbre bundles (solid arrows) and endotenon regions (dashed arrows) is indicated. (B) Transverse
sections of compressed tendon (I, II), tensional tendon (III, IV) and cornea (V), immunolabelled with mAb KER-1, and counterstained with DAPI.
Images are presented as red/green anaglyphswhere positive immunolabelling is shown in green and cell nuclei in red (areas of co-localisation of
keratocan immunolabelling with tendon cells are shown in yellow). Positive immunolabelling of tendon collagen ﬁbre bundles (solid arrows) and
endotenon regions (dashed arrows) is indicated (IeIV). Tendon sections with the primary antibody omitted showed no immunolabelling (VI).
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Fig. 2. Western blot analyses of tissue extracts of cornea, tensional
tendon (T-tend), compressed tendon (C-tend) and articular carti-
lage (Cart), immunolocated with mAb KER-1 which recognises
the keratocan core protein. Samples were digested without (A) or
with (B) endo-b-galactosidase (þb-endo) to remove KS chains.
Loading of samples onto the gels was standardised by loading on
the basis of equivalent protein content of tissue extract (30 mg).
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mAb KER-1 was carried out as previously described12). Vis-
ualisation was achieved using a ﬂuorescein isothiocyanate
(FITC)-conjugated goat anti-mouse secondary antibody
(Dako, UK) and sections mounted in mounting-medium
containing 40,6 diamidino-2-phenylindole (DAPI, Vecta-
shield, Vector Laboratories). Immunohistochemical controls
(as previously described13) showed no immunolabelling.
Sections were viewed under epiﬂuorescence using an
Olympus BX61 microscope with appropriate ﬁlters for
FITC and DAPI and equipped with digital image acquisition.
Images were presented as red/green anaglyphs. In a series
of separate experiments, dual-immunolabelling of tendon
sections with antibodies to both type I collagen (rabbit poly-
clonal antibody 70-XR90, Fitzgerald Industries, USA) and
keratocan (mAb KER-1) was carried out, showing their rela-
tive distributions in the tendon matrix, as a morphological
reference. In addition, bovine corneas were cryosectioned
and immunolabelled with mAb KER-1, as previously
described12.
For sodium dodecyl sulphate/polyacrylamide gel electro-
phoresis (SDS/PAGE) and Western blot analyses, tissue
samples (tendon, cartilage or cornea) were ﬁnely diced
and proteoglycans extracted twice at 4C for 24 h with 15
volumes (w/v) of 4 M guanidineeHCl, 50 mM sodium ace-
tate, pH 6.6, containing proteinases inhibitors5. The protein
and sulphated glycosaminoglycan (GAG) content of extracts
were subsequently determined using Bio-Rad DC protein
assay (Bio-Rad Laboratories, UK) and dimethylmethylene
blue (DMMB; Serva) colourimetric assay14, respectively.
Samples were then treated with or without endo-b-galactosi-
dase (Seikagaku; 0.1 mU/10 mg GAG) in 0.2 M sodium
acetate, 10 mM ethylenediaminetetra-acetate (EDTA), pH
5.8 for 1 h at 37C, prior to separation by SDS/PAGE and
Western blotting analysis (as previously described5), utilis-
ing mAb KER-1 (1:1000) which recognises the keratocan
core protein12. Loading of samples onto the gels was stand-
ardised by loading on the basis of equivalent protein content
(30 mg of total protein per sample).
The results of immunohistochemical analyses are shown
in Fig. 1. As expected, dual-immunolabelling studies re-
vealed that type I collagen immunoreactive material was as-
sociated with the collagen ﬁbre bundles and was also
present in the endotenon, surrounding the collagen bun-
dles. Keratocan immunolabelling showed a similar distribu-
tion, with strong co-localisation of type I collagen/keratocan
immunostaining occurring around the collagen ﬁbres bun-
dles [Fig. 1(A)], compressed tendon only shown, however,
similar results were obtained for tensional tendon]. Further
investigation of the distribution of keratocan in compressed
vs tensional tendon and cornea was performed [Fig. 1(B)].
Tissue sections of compressed tendon [Fig. 1(B)-I and II]
showed a higher collagen bundle density compared with
tensional tendon [Fig. 1(B)-III and IV] which may be attrib-
uted to the reduced collagen ﬁbril diameter of the com-
pressed region10). However, a similar pattern of keratocan
immunoreactivity occurred in the two regions, with positive
immunolabelling present in both the collagen ﬁbre bundles
and in the endotenon. In addition, KER-1 immunolabelling
co-localised with the cells, which is likely to be associated
with the synthesis/secretion of keratocan by the tenocytes
and/or the modulation of cell function by this SLRP (in this
regard, cell-associated keratocan has been shown to be
present in the corneal epithelium12 and various members
of the SLRP family have been demonstrated to affect cellu-
lar responses2). In tissue sections of cornea, intense immu-
nolabelling for keratocan occurred, and was associated withthe collagen ﬁbres in the corneal stroma [Fig. 1(B)-V]. Neg-
ative controls showed no immunolabelling [Fig. 1(B)-VI].
Our data are consistent with previous studies which dem-
onstrate that close and speciﬁc interactions occur between
SLRPs and collagen ﬁbrils in various connective tissues, in-
cluding tendon and cornea2. Interestingly, the immunolocal-
isation pattern of keratocan (Fig. 1) is similar to that of
decorin within mouse tendon, with positive immunostaining
occurring in both tendon collagen bundles and surrounding
connective tissues (endotenon regions)15. This distribution
was distinct to that reported for both ﬁbromodulin and lumi-
can, where staining was localised to either the collagen
ﬁbre bundles or the surrounding tissues, respectively, in
the wild type animal15. As collagen ﬁbrils are important con-
stituents of the endotenon1, it is therefore likely that certain
SLRPs (e.g., keratocan and lumican) are involved in the reg-
ulation of collagenous components within this loose matrix.
The results of Western blot analyses are shown in Fig. 2.
Differences were apparent in the relative abundance of ker-
atocan to total protein in the various tissues examined, with
cornea and compressed tendon exhibiting the most intense
immunostaining (consistent with the high proteoglycan
content of tendon ﬁbrocartilage4), compared with little im-
munoreactivity in cartilage extracts [Fig. 2(A)]. In addition,
variations were apparent in post-translational modiﬁcations
(i.e., GAG substitutions) in keratocan derived from these
279Osteoarthritis and Cartilage Vol. 17, No. 2tissues. For example, keratocan immunoreactivity in cornea
was detected as heterogeneous bands, ranging in molecu-
lar mass fromw35 kDa tow75 kDa, indicative of a glycosy-
lated core protein, whereas keratocan derived from tendon
and cartilage exhibited little glycosylation, with immunopos-
itive bands ranging from w35 kDa to w46 kDa. In order to
conﬁrm this, tissue samples were digested with endo-b-ga-
lactosidase (which speciﬁcally hydrolyses the b-galactosidic
linkages of non-sulphated galactosyl residues in KS and
has weaker speciﬁcity for mono-sulphated galactosyl resi-
dues); this resulted in a reduction in molecular mass of
the corneal keratocan following Western blotting, in contrast
to tendon [Fig. 2(B)] and cartilage samples (data not
shown), which showed little change in the range of immuno-
positive staining. Taken together, these data indicate that
the core protein of adult corneal keratocan is highly glycosy-
lated, whereas in tendon and cartilage, the KSeGAGs in this
SLRP are poorly sulphated, non-sulphated or not present.
However, it is important to note that certain KSeSLRPs
(e.g., ﬁbromodulin) have been shown to be poorly
substituted with KS in the adult, but to possess KS chains
in the juvenile16, raising the possibility that age-related
changes may also occur in keratocan glycosylation. Interest-
ingly, keratocanwithminimally sulphated KS chains (such as
that present in tendon, as well as other non-corneal tissues)
has the potential to affect cellular responses17, in a similar
fashion to other members of the SLRP family2.
In conclusion, the results of this study demonstrate that
keratocan, previously thought to be ‘corneal-speciﬁc’ in adult
tissues, is abundant in tendon and, as such, is likely to play
an important part in regulating its collagenous matrix, a pro-
cess vital to the correct physiological functioning of this tissue.Conﬂict of interest
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